You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has carried out a directed share issue of approximately 170 million SEK at a subscription price of SEK 72 per share. The subscription price was determined through an accelerated book-building procedure. A number of Swedish and institutional investors, including Systematic Group AB (AsAlready a subscriber Login You have…
Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult win £1.5M innovate UK grant. Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work with CoAlready a subscriber Login You have read all…
The Board of Directors of the Finnish biotech company FIT Biotech has decided to file an application for bankruptcy, reports Huvudstadsbladet. The reason behind the decision is that a financing contract has been terminated. Despite the fact that one financing agreement is still effective, the invAlready a subscriber Login You…
Asarina Pharma, a drug development company focused on the development of a novel therapy for severe premenstrual symptoms, has completed a financing round raising EURO 7 million from new and existing investors for the continued clinical development of Sepranolone. Around 5% of women in fertile agAlready a subscriber Login You…
